Association of cerebral blood flow with the development of cardiac death or urgent heart transplantation in patients with systolic heart failure

European Heart Journal

Volumn 33, Issue 3, 2012, Pages 354-362

  Kim, Min Seok ^a   Kim, Jae Seung ^a   Yun, Sung Cheol ^a   Lee, Cheol Whan ^a   Song, Jae Kwan ^a   Park, Seong Wook ^a   Park, Seung Jung ^a   Kim, Jae Joong ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cerebral blood flow; Heart transplantation; Prognosis; Systolic heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARBON DIOXIDE; CREATININE; SODIUM;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; LUNG ARTERY PRESSURE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCINTIANGIOGRAPHY; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; SYSTOLIC HEART FAILURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; BLOOD FLOW VELOCITY; CARBON DIOXIDE; CEREBROVASCULAR CIRCULATION; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; EMERGENCY TREATMENT; EXERCISE TEST; FEMALE; HEART FAILURE, SYSTOLIC; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84863012854     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr345     Document Type: Article

References (30)

1. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159.
2. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in congestive heart failure. Eur Heart J 1998;19:696-710. (Pubitemid 28227152)
3. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95: 2660-2667. (Pubitemid 27255495)
4. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433. (Pubitemid 43739439)
5. Ingle L. Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail Rev 2007;12: 12-22. (Pubitemid 46629243)
6. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984;311:874-877. (Pubitemid 14041544)
7. HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301: 1439-1450.
8. HF-ACTION Investigators. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J 2009;158:S72-S77.
9. Wanless RB, Anand IS, Gurden J, Harris P, Poole-Wilson PA. Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of iso-sorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 1987;243: 1101-1106. (Pubitemid 18017167)
10. Gruhn N, Larsen FS, Boesgaard S, Knudsen GM, Mortensen SA, Thomsen G, Aldershvile J. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001;32:2530-2533. (Pubitemid 33055301)
11. Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, Hong MK, Song JK, Park SW, Park SJ, Kim JJ. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2006;97:1365-1369.
12. Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hex-amethylpropylene amine oxime. Eur J Nucl Med 1995;22:633-637.
13. Matsuda H, Tsuji S, Shuke N, Sumiya H, Tonami N, Hisada K. A quantitative approach to technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1992;19:195-200.
14. Bard RL, Gillespie BW, Clarke NS, Egan TG, Nicklas JM. Determining the best ventilatory efficiency measure to predict mortality in patients with heart failure. J Heart Lung Transplant 2006;25:589-595.
15. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-2027. (Pubitemid 16066969)
16. Therneau TM, Grambsch PM, Fleming TR. Martingale based residuals for survival models. Biometrika 1990;77:147-160.
17. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337-344. (Pubitemid 30422619)
18. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-524. (Pubitemid 29135805)
19. PROGRESS Collaborative Group. Effects of blood pressure lowering with peri-ndopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-1075.
20. GIFA Study Group. Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 2005;26:226-233.
21. Ueda T, Mizushige K, Yukiiri K, Takahashi T, Kohno M. Improvement of cerebral blood flow by olprinone, a phosphodiesterase-3 inhibitor, in mild heart failure. Cerebrovasc Dis 2003;16:396-401. (Pubitemid 37140430)
22. Lee CW, Lee JH, Kim JJ, Park SW, Hong MK, Kim ST, Lim TH, Park SJ. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 1999;33:1196-1202.
23. Bouma GJ, Muizelaar JP. Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation. J Neurosurg 1990;73: 368-374. (Pubitemid 20260005)
24. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-786.
25. Wilson JR, Rayos G, Yeoh TK, Gothard P. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. J Am Coll Cardiol 1995;26:429-435.
26. Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ven-tilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 2002; 143:418-426. (Pubitemid 34185171)
27. Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Failure Rev 2008;13:245-269.
28. Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002;106:3079-3084. (Pubitemid 35440292)
29. Sun XG, Hansen JE, Garatachea N, Storer TW, Wasserman K. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 2002;166: 1443-1448. (Pubitemid 35387293)
30. Sudden Cardiac Death in Heart Failure Trial Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.